BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, July 7, 2026
Home » Authors » Amanda Pedersen

Amanda Pedersen

Articles

ARTICLES

Few regret elective removal of healthy breast years later

May 2, 2011
By Amanda Pedersen

Walking the med-tech Red Carpet

April 28, 2011
By Amanda Pedersen
A story about DSM Biomedical (Berkeley, California) that appeared in Thursday’s issue of Medical Device Daily drew a comparison between companies like DSM and the film industry’s production crew that works behind the scenes adding invaluable elements to help make the movie a success but are much less recognized and appreciated than the starring cast members. So just for fun let’s imagine what it would be like if the med-tech industry had its own televised version of the Academy Awards. Instead of an Oscar, the coveted trophy would resemble a big gold stent. Before the show CEOs from big players...
Read More

DSM plays behind the scenes role in device development

April 28, 2011
By Amanda Pedersen

First patient enrolled in INOVATE-HF for CardioFit

April 27, 2011
By Amanda Pedersen

Report from Europe: Kuros regains rights from Baxter for KUR candidates

April 27, 2011
By Amanda Pedersen

Gore reports the enrollment of first TIPS study patient

April 26, 2011
By Amanda Pedersen

Green-eyed with med-tech envy

April 22, 2011
By Amanda Pedersen
I’m not proud to admit this, but once in a while I do get bit by the green-eyed monster – only when it comes to medical innovation though. Hey, nobody’s perfect – right? About eight years ago I had major colorectal surgery following a pretty wicked battle with ulcerative colitis. Basically the surgeon had to take out my entire colon, creating a stoma (artificial opening in the abdomen wall through which the end of the intestine is brought). I wore an ileostomy bag for 15 months before having a “take down” surgery so that I no longer needed the bag...
Read More

Healthcare industry may soon see increased M&A activity

April 22, 2011
By Amanda Pedersen

FDA approves St. Jude's new Trifecta heart valve

April 21, 2011
By Amanda Pedersen

AlloMap test has expanded use heart transplant patients

April 19, 2011
By Amanda Pedersen
View All Articles by Amanda Pedersen

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 6, 2026.
  • CINP 2026: Prenatal and adolescent stress shape brain vulnerability

    BioWorld Science
    Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
  • Illustration of brain and brain waves, concept of focal seizure

    Hyperexcitability may be joint problem in epilepsy, dementia

    BioWorld
    The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
  • Modius Spero wearable neuromodulation device

    Neurovalens granted FDA approval for PTSD therapy for US veterans

    BioWorld
    Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
  • 3D rendering of antibody drug conjugated with cytotoxic payload

    Novartis to pay $1.5B for Myricx Bio and its novel ADC payloads

    BioWorld
    Novartis AG is to pay $1.1 billion up front to acquire Myricx Bio Ltd., a preclinical-stage antibody-drug conjugate (ADC) specialist that is advancing a novel and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing